exercise on semaglutide & If You're on a GLP-1,
Description
In 2021, FDA approved Novos Wegovy for chronic weight management
Considering the network that bi-directionally links obesity and insulin resistance in the pathogenesis of PCOS, it seems to be particularly appealing a new approach producing, at the same time, satisfactory and permanent weight loss, improvement in insulin resistance and in metabolic profile, with additional favourable outcomes on reproductive and cardiovascular systems (19)
Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial
Whilst generally well-tolerated, some patients report experiencing tiredness during treatment
Ozempic rebound refers to the weight gain that occurs after the medication has been stopped
Research shows caloric reductions between 16% and 39% depending on the medication and dose
